[Federal Register Volume 80, Number 178 (Tuesday, September 15, 2015)]
[Notices]
[Pages 55395-55397]
[FR Doc No: 2015-23106]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-75867]

ISE Mercury, LLC; Order Granting Application for a Conditional
Exemption Pursuant to Section 36(a) of the Exchange Act From Certain
Requirements of Rules 6a-1 and 6a-2 Under the Exchange Act

September 9, 2015.

I. Introduction

    On September 29, 2014, ISE Mercury, LLC (``Applicant'') submitted
to the Securities and Exchange Commission (``Commission'') an
application on Form 1 under the Securities Exchange Act of 1934
(``Exchange Act'') to register as a national securities exchange. In
connection with this application, the Applicant, pursuant to Exchange
Act Rule 0-12,\1\ has requested an exemption under Section 36(a)(1) of
the Exchange Act \2\ from certain requirements of Exchange Act Rules
6a-1(a) and 6a-2 (``Exemption Request'').\3\ This order grants the
Applicant's request for exemptive relief, subject to the satisfaction
of certain conditions, which are outlined below.
---------------------------------------------------------------------------

    \1\ 17 CFR 240.0-12.
    \2\ 15 U.S.C. 78mm(a)(1).
    \3\ 17 CFR 240.6a-1(a) and 6a-2. See letter from Michael Simon,
Secretary and General Counsel, ISE Mercury, LLC, to Brent J. Fields,
Secretary, Commission, dated June 26, 2015.
---------------------------------------------------------------------------

II. Application for Conditional Exemption from Certain Requirements of
Exchange Act Rules 6a-1 and 6a-2

A. Filing Requirements Under Exchange Act Rule 6a-1(a)

    Exchange Act Rule 6a-1(a) requires an applicant for registration as
a national securities exchange to file an application with the
Commission on Form 1. Exhibit C to Form 1 requires the applicant to
provide certain information with respect to each of its subsidiaries
and affiliates.\4\ For purposes of Form 1, an ``affiliate'' is ``[a]ny
person that, directly or indirectly, controls, is under common control
with, or is controlled by, the national securities exchange . . .
including any employees.'' \5\ Form 1 defines ``control'' as ``[t]he
power, directly or indirectly, to direct the management or policies of
a company, whether through ownership of securities, by contract, or
otherwise . . . .'' \6\ Form 1 provides, further, that any person that
directly or indirectly has the right to vote 25% or more of a class of
voting securities, or has the power to sell or direct the sale of 25%
or more of a class of voting securities, is presumed to control the
entity.\7\
---------------------------------------------------------------------------

    \4\ Specifically, Exhibit C requires the applicant to provide,
for each subsidiary or affiliate, and for any entity with whom the
applicant has a contractual or other agreement relating to the
operation of an electronic trading system used to effect
transactions on the exchange: (1) The name and address of the
organization; (2) the form of organization; (3) the name of the
state and statute citation under which it is organized, and the date
of its incorporation in its present form; (4) a brief description of
the nature and extent of the affiliation; (5) a brief description of
the organization's business or functions; (6) a copy of the
organization's constitution; (7) a copy of the organization's
articles of incorporation or association, including all amendments;
(8) a copy of the organization's by-laws or corresponding rules or
instruments; (9) the name and title of the organization's present
officers, governors, members of all standing committees, or persons
performing similar functions; and (10) an indication of whether the
business or organization ceased to be associated with the applicant
during the previous year, and a brief statement of the reasons for
termination of the association.
    \5\ Form 1 Instructions, Explanation of Terms, 17 CFR 249.1.
    \6\ Id.
    \7\ Id.
---------------------------------------------------------------------------

    Exhibit D to Form 1 requires an applicant for registration as a
national securities exchange to provide unconsolidated financial
statements for the latest fiscal year for each subsidiary or affiliate.
Exhibit D requires the financial statements to include, at a minimum, a
balance sheet and an income statement with such footnotes and other
disclosures as are necessary to avoid rendering the financial
statements misleading. Exhibit D provides, in addition, that if any
affiliate or subsidiary of the applicant is required by another
Commission rule to submit annual financial statements, a statement to
that effect, with a citation to the other Commission rule, may be
provided in lieu of the financial statements required in Exhibit D.
    A Form 1 application is not considered filed until all necessary
information, including financial statements and other required
documents, have been furnished in the proper form.\8\
---------------------------------------------------------------------------

    \8\ 17 CFR 202.3(b)(2). See also 17 CFR 240.0-3(a). Defective
Form 1 applications ``may be returned with a request for correction
or held until corrected before being accepted as a filing.'' See 17
CFR 202.3(b)(2). See also Securities Exchange Act Release No. 40760
(December 8, 1998), 63 FR 70844, 70881 (December 22, 1998)
(``Regulation ATS Adopting Release'') at note 329 and accompanying
text.
---------------------------------------------------------------------------

B. Filing Requirements under Exchange Act Rule 6a-2

    Exchange Act Rule 6a-2(a)(2) requires a national securities
exchange to update the information provided in Exhibit C within 10 days
of any action that causes the information provided in Exhibit C to
become inaccurate or incomplete. In addition, Exchange Act Rule 6a-
2(b)(1) requires a national securities exchange to file Exhibit D on or
before June 30 of each year, and Exchange Act Rule 6a-2(c) requires a
national securities exchange to file Exhibit C every three years.

C. Exemption Request

    On June 26, 2015, the Applicant requested that the Commission grant
an exemption under Section 36 of the Exchange Act from the requirement
under Exchange Act Rule 6a-1 to file the information requested of the
Applicant in Exhibits C and D to Form 1 for the ``Foreign Indirect
Affiliates,'' as defined below.\9\ In addition, the Applicant requested
an exemption, subject to certain conditions, with respect to the
Foreign Indirect Affiliates from the requirements under: (1) Exchange
Act Rule 6a-2(a)(2) to amend Exhibit C within 10 days if the
information in Exhibit C becomes inaccurate or incomplete; and (2)
Exchange Act Rules 6a-2(b)(1) and (c) to

file periodic updates to Exhibits C and D.
---------------------------------------------------------------------------

    \9\ See Exemption Request, supra note 3.
---------------------------------------------------------------------------

    The Applicant is a wholly-owned subsidiary of International
Securities Exchange Holdings, Inc. (``ISE Holdings'').\10\ ISE Holdings
is a wholly-owned subsidiary of U.S. Exchange Holdings, Inc., which is
15% owned by Deutsche B[ouml]rse AG (``Deutsche B[ouml]rse'') and 85%
owned by a German stock corporation, Eurex Frankfurt AG (``Eurex
Frankfurt''). Eurex Frankfurt is wholly-owned by Deutsche B[ouml]rse.
According to the Applicant, the parent ownership structure of U.S.
Exchange Holdings, Inc. is comprised entirely of foreign entities,
Eurex Frankfurt and Deutsche B[ouml]rse (collectively, the ``Foreign
Direct Affiliates''), which in turn hold ownership interests, either
directly or indirectly, in excess of 25% in a large number of other
foreign entities, some of which also own interests in other entities in
excess of 25% as well (such Foreign Direct Affiliate-owned entities are
referred to, collectively, as the ``Foreign Indirect Affiliates'').\11\
---------------------------------------------------------------------------

    \10\ See Exemption Request, supra note 3, at 2.
    \11\ See id.
---------------------------------------------------------------------------

    Because of the limited and indirect nature of its connection to the
Foreign Indirect Affiliates, the Applicant believes that the corporate
and financial information of the Foreign Indirect Affiliates required
by Exhibits C and D of Form 1 would have little relevance to the
Commission's review of the Applicant's Form 1 application or, if the
Commission were to approve the Applicant's Form 1 application, as
amended, to the Commission's ongoing oversight of the Applicant as a
national securities exchange.\12\ In this regard, the Exemption Request
states that the Foreign Indirect Affiliates have no ability to
influence the management, policies, or finances of the Applicant and no
obligation to provide funding to, or ability to materially affect the
funding of, the Applicant.\13\ The Exemption Request also states that:
(1) The Foreign Indirect Affiliates have no ownership interest in the
Applicant or in any of the controlling shareholders of the Applicant;
and (2) there are no commercial dealings between the Applicant and the
Foreign Indirect Affiliates.\14\ Further, the Exemption Request states
that obtaining detailed corporate and financial information with
respect to the Foreign Indirect Affiliates (1) is unnecessary for the
protection of investors and the public interest and (2) would be unduly
burdensome and inefficient because these affiliates are located in
foreign jurisdictions and the disclosure of such information could
implicate foreign information sharing restrictions in such
jurisdictions.\15\
---------------------------------------------------------------------------

    \12\ See id. at 2-3.
    \13\ See Exemption Request, supra note 3, at 3.
    \14\ See id. The Applicant states that ``commercial dealings''
means any direct or indirect arrangement, agreement, or
understanding or any other relationship including, but not limited
to, the providing of hardware, software, technology services or any
other goods or services that support the operation of ISE Mercury or
any facility of ISE Mercury. See id., supra note 3, at 3 n. 5.
    \15\ See id. The Applicant also believes that providing the
information required by Exhibits C and D with respect to the Foreign
Indirect Affiliates could raise confidentiality concerns because
many of the Foreign Indirect Affiliates are not public companies.
Id.
---------------------------------------------------------------------------

    As a condition to the granting of exemptive relief, the Applicant
has agreed to provide: (i) A listing of the names of the Foreign
Indirect Affiliates; (ii) an organizational chart setting forth the
affiliation of the Foreign Indirect Affiliates and the Foreign Direct
Affiliates and the Applicant; and (iii) in Exhibit C of the Applicant's
Form 1 application, a description of the nature of the Foreign Indirect
Affiliates' affiliation with the Foreign Direct Affiliates and the
Applicant. In addition, as a condition to the granting of exemptive
relief from the requirements of Exchange Act Rule 6a-2(a)(2), 6a-
2(b)(1), and 6a-2(c), as described above, the Applicant has agreed to
provide amendments to the information required under conditions (i)
through (iii) above on or before June 30th of each year. Further, the
Applicant notes that it will provide the information required by
Exhibits C and D for all of its affiliates other than the Foreign
Indirect Affiliates, including the Foreign Direct Affiliates.\16\
---------------------------------------------------------------------------

    \16\ See Exemption Request, supra note 3, at 3.
---------------------------------------------------------------------------

III. Order Granting Conditional Section 36 Exemption

    Section 6 of the Exchange Act \17\ sets forth a procedure for an
exchange to register as a national securities exchange.\18\ Exchange
Act Rule 6a-1(a) \19\ requires an application for registration as a
national securities exchange to be filed on Form 1 in accordance with
the instructions in Form 1. A Form 1 application is not considered
filed until all necessary information, including financial statements
and other required documents, has been furnished in the proper
form.\20\ Exchange Act Rule 6a-2 establishes ongoing requirements to
file certain amendments to Form 1.
---------------------------------------------------------------------------

    \17\ 15 U.S.C. 78f.
    \18\ Specifically, Section 6(a) of the Exchange Act states that
``[a]n exchange may be registered as a national securities exchange
. . . by filing with the Commission an application for registration
in such form as the Commission, by rule, may prescribe containing
the rules of the exchange and such other information and documents
as the Commission, by rule, may prescribe as necessary or
appropriate in the public interest or for the protection of
investors.'' Section 6 of the Exchange Act also sets forth various
requirements to which a national securities exchange is subject.
    \19\ 17 CFR 240.6a-1(a).
    \20\ 17 CFR 202.3(b)(2). See also supra note 8.
---------------------------------------------------------------------------

    Section 36(a)(1) of the Exchange Act provides that ``the
Commission, by rule, regulation, or order, may conditionally or
unconditionally exempt any person, security, or transaction, or any
class or classes of persons, securities, or transactions, from any
provision or provisions of [the Exchange Act] or of any rule or
regulation thereunder, to the extent that such exemption is necessary
or appropriate in the public interest, and is consistent with the
protection of investors.'' \21\ For the reasons discussed below, the
Commission believes that it is appropriate in the public interest and
consistent with the protection of investors to exempt the Applicant
from the requirement under Exchange Act Rule 6a-1 to provide the
information required in Exhibits C and D to Form 1 with respect to the
Foreign Indirect Affiliates, subject to the following conditions:
---------------------------------------------------------------------------

    \21\ 15 U.S.C. 78mm(a)(1).
---------------------------------------------------------------------------

    (1) The Applicant must provide a list of the names of the Foreign
Indirect Affiliates;
    (2) the Applicant must provide an organizational chart setting
forth the affiliation of the Foreign Indirect Affiliates and the
Foreign Direct Affiliates and the Applicant; and
    (3) as part of Exhibit C to the Applicant's Form 1 Application, the
Applicant must provide a description of the nature of the affiliation
between the Foreign Indirect Affiliates and the Foreign Direct
Affiliates and the Applicant.
    The Commission believes, further, that it is appropriate in the
public interest and consistent with the protection of investors to
exempt the Applicant, with respect to the Foreign Indirect Affiliates,
from the requirements under: (a) Exchange Act Rule 6a-2(a)(2) to amend
Exhibit C within 10 days of any action that renders the information in
Exhibit C inaccurate or incomplete; (b) Exchange Act Rules 6a-2(c) to
provide periodic updates of Exhibit C; and (c) Exchange Act Rules 6a-
2(b)(1) to provide periodic updates of Exhibit D, subject to the
condition that the Applicant provide amendments to the information
required under conditions (1) through (3) above on or before June 30th
of each year.
    As part of an application for exchange registration, the
information included in

Exhibits C and D is designed to help the Commission make the
determinations required under Sections 6(b) and 19(a) of the Exchange
Act \22\ with respect to the application. The updated Exhibit C and D
information required under Exchange Act Rule 6a-2 is designed to help
the Commission exercise its oversight responsibilities with respect to
national securities exchanges. Specifically, Exhibit D is designed to
provide the Commission with information concerning the financial status
of an exchange and its affiliates and subsidiaries,\23\ and Exhibit C
is designed to provide the Commission with the names and organizational
documents of these affiliates and subsidiaries.\24\ Such information is
designed to help the Commission determine whether an applicant for
exchange registration would have, and a national securities exchange
continues to have, the ability to carry out its obligations under the
Exchange Act.
---------------------------------------------------------------------------

    \22\ 15 U.S.C. 78f(b) and 78s(a).
    \23\ See Securities Exchange Act Release No. 18843 (June 25,
1982), 47 FR 29259 (July 6, 1982) (proposing amendments to Form 1);
see also Form 1, 17 CFR 249.1, and supra Section II.A.
    \24\ Form 1, 17 CFR 249.1. See also supra note 4.
---------------------------------------------------------------------------

    Since the most recent amendments to Form 1 in 1998,\25\ many
national securities exchanges that previously were member-owned
organizations with few affiliated entities have demutualized. Some of
these demutualized exchanges have consolidated under holding companies
with numerous affiliates that, in some cases, have only a limited and
indirect connection to the national securities exchange, with no
ability to influence the management or policies of the registered
exchange, and no obligation to fund, or to materially affect the
funding of, the registered exchange. The Commission believes that, for
these affiliated entities, the information required under Exhibits C
and D would have limited relevance to the Commission's review of an
application for exchange registration or to its oversight of a
registered exchange.
---------------------------------------------------------------------------

    \25\ See Regulation ATS Adopting Release, supra note 8, at
Section IV.C.
---------------------------------------------------------------------------

    Based on the Applicant's representations, the indirect nature of
the relationship between the Applicant and the Foreign Indirect
Affiliates, and the information that the Applicant will provide with
respect to the Foreign Direct Affiliates and the Foreign Indirect
Affiliates, the Commission believes that it will have sufficient
information to review the Applicant's Form 1 application and to make
the determinations required under Sections 6(b) and 19(a) of the
Exchange Act with respect to its application for registration as a
national securities exchange.\26\ The Commission believes, further,
that if the Commission were to approve the Applicant's Form 1
application, it will have the information necessary to oversee the
Applicant's activities as a national securities exchange. In
particular, the Commission notes that the Applicant has represented
that it would have no direct connection to the Foreign Indirect
Affiliates, that the Foreign Indirect Affiliates would have no ability
to influence the management or policies of the Applicant, and that the
Foreign Indirect Affiliates would have no obligation to fund, or
ability to materially affect the funding of, the Applicant. In
addition, the Commission notes that the Applicant has represented that:
(1) The Foreign Indirect Affiliates have no ownership interest in the
Applicant or in any of the controlling equity holders of the Applicant;
and (2) there are no commercial dealings between the Applicant and the
Foreign Indirect Affiliates.\27\
---------------------------------------------------------------------------

    \26\ 15 U.S.C. 78f(b) and 78s(a). Section 6(b) of the Exchange
Act enumerates certain determinations that the Commission must make
with respect to an exchange before granting the registration of the
exchange as a national securities exchange. The Commission will not
grant an exchange registration as a national securities exchange
unless the Commission determines that the exchange meets these
requirements. See Regulation ATS Adopting Release, supra note 8, at
Section IV.B.
    \27\ See Exemption Request, supra note 3, at 3; supra note 15.
---------------------------------------------------------------------------

    Given the limited and indirect relationship between the Applicant
and the Foreign Indirect Affiliates, as described above, the Commission
believes that the detailed corporate and financial information required
in Exhibits C and D with respect to the Foreign Indirect Affiliates is
unnecessary for the Commission's review of the Applicant's Form 1
application and would be unnecessary for the Commission's oversight of
the Applicant as a registered national securities exchange following
any Commission approval of its Form 1 application.
    For the reasons discussed above, the Commission finds that the
conditional exemptive relief requested by the Applicant is appropriate
in the public interest and is consistent with the protection of
investors.
    The Commission may modify by order the terms, scope or conditions
of this exemption if it determines that such modification is necessary
or appropriate in the public interest, or is consistent with the
protection of investors. Furthermore, the Commission may limit,
suspend, or revoke this exemption if it finds that the Applicant has
failed to comply with, or is unable to comply with, any of the
conditions set forth in this order, if such action is necessary or
appropriate in the public interest, or is consistent with the
protection of investors.
    It is ordered, pursuant to Section 36 of the Exchange Act,\28\ that
the Applicant is exempt from the requirements to: (1) Include in its
Form 1 application the information required in Exhibits C and D to Form
1 with respect to the Foreign Indirect Affiliates; and (2) with respect
to the Foreign Indirect Affiliates, update the information in Exhibits
C and D to Form 1 as required by Exchange Act Rules 6a-2(a)(2), 6a-
2(b)(1), and 6a-2(c) subject to the following conditions:
---------------------------------------------------------------------------

    \28\ 15 U.S.C. 78mm.
---------------------------------------------------------------------------

    (i) The Applicant must provide a list of the names of the Foreign
Indirect Affiliates;
    (ii) the Applicant must provide an organizational chart setting
forth the affiliation of the Foreign Indirect Affiliates and the
Foreign Direct Affiliates and the Applicant; and
    (iii) as part of Exhibit C to the Applicant's Form 1 Application,
the Applicant must provide a description of the nature of the
affiliation between the Foreign Indirect Affiliates and the Foreign
Direct Affiliates and the Applicant.
    In addition, the Applicant must provide amendments to the
information required under conditions (i) through (iii) above on or
before June 30th of each year.

    By the Commission.
Robert W. Errett,
Deputy Secretary.
[FR Doc. 2015-23106 Filed 9-14-15; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 82, Number 49 (Wednesday, March 15, 2017)]
[Notices]
[Pages 13822-13823]
[FR Doc No: 2017-05100]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0719]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Guidance for Industry
on Planning for the Effects of High Absenteeism To Ensure Availability
of Medically Necessary Drug Products

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995 (PRA).

DATES: Fax written comments on the collection of information by April
14, 2017.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX:<PHONE_NUMBER>, or emailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0675.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD 20852<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Guidance for Industry on Planning for the Effects of High Absenteeism
To Ensure Availability of Medically Necessary Drug Products OMB Control
Number 0910-0675--Extension

    The guidance recommends that manufacturers of drug and therapeutic
biological products and manufacturers of raw materials and components
used in those products develop a written Emergency Plan (Plan) for
maintaining an adequate supply of medically necessary drug products
(MNPs) during an emergency that results in high employee absenteeism.
The guidance discusses the issues that should be covered by the Plan,
such as: (1) Identifying a person or position title (as well as two
designated alternates) with the authority to activate and deactivate
the Plan and make decisions during the emergency; (2) prioritizing the
manufacturer's drug products based on medical necessity; (3)
identifying actions that should be taken prior to an anticipated period
of high absenteeism; (4) identifying criteria for activating the Plan;
(5) performing quality risk assessments to determine which
manufacturing activities may be reduced to enable the company to meet a
demand for MNPs; (6) returning to normal operations and conducting a
post-execution assessment of the execution outcomes; and (7) testing
the Plan. The guidance recommends developing a Plan for each individual
manufacturing facility as well as a broader Plan that addresses
multiple sites within the organization. For purposes of this
information collection analysis, we consider the Plan for an individual
manufacturing facility as well as the broader Plan to comprise one Plan
for each manufacturer. Based on FDA's data on the number of
manufacturers that would be covered by the guidance, we estimate that
approximately 70 manufacturers will develop a Plan as recommended by
the guidance (i.e., one Plan per manufacturer to include all
manufacturing facilities, sites, and drug products), and that each Plan
will take approximately 500 hours to develop, maintain, and update.
    The guidance also encourages manufacturers to include a procedure
in their Plan for notifying the Center for Drug Evaluation and Research
(CDER) when the Plan is activated and when returning to normal
operations. The guidance recommends that these notifications occur
within 1 day of a Plan's activation and within 1 day of a Plan's
deactivation. The guidance specifies the information that should be
included in these notifications, such as which drug products will be
manufactured under altered procedures, which products will have
manufacturing temporarily delayed, and any anticipated or potential
drug shortages. We expect that approximately two notifications (for
purposes of this analysis, we consider an activation and a deactivation
notification to equal one notification) will be sent to CDER by
approximately two manufacturers each year, and that each notification
will take approximately 16 hours to prepare and submit.
    The guidance also refers to previously approved collections of
information found in FDA regulations. Under the guidance, if a
manufacturer obtains information after releasing an MNP under its Plan
leading to suspicion that the product might be defective, CDER should
be contacted immediately at<EMAIL_ADDRESS>in adherence to
existing recall reporting regulations (21 CFR 7.40) (OMB control number
0910-0249), or defect reporting requirements for drug application
products (21 CFR 314.81(b)(1)) and therapeutic biological products
regulated by CDER (21 CFR 600.14) (OMB control numbers 0910-0001 and
0910-0458, respectively).
    In addition, the following collections of information found in FDA
current good manufacturing practice (CGMP) regulations in part 211 (21
CFR part 211) are approved under OMB control number 0190-0139. The
guidance encourages manufacturers to maintain records, in accordance
with the CGMP requirements (see, e.g., Sec.  211.180) that support
decisions to carry out changes to approved procedures for manufacturing
and release of products under the Plan. The guidance states that a Plan
should be developed, written, reviewed, and approved within the site's
change control quality system in accordance with the requirements in
Sec. Sec.  211.100(a) and 211.160(a); execution of the Plan should be
documented in accordance with the requirements described in Sec.
211.100(b); and standard operating procedures should be reviewed and
revised or supplementary procedures developed and approved to enable
execution of the Plan.
    In the Federal Register of November 3, 2016 (81 FR 76618), we
published a 60-day notice requesting public comment on the proposed
extension of this collection of information. No comments were received
in response to the notice.
    We estimate the burden of this information collection as follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                               Number of
                Absenteeism guidance                       Number of         responses per       Total annual     Average burden per      Total hours
                                                          respondents         respondent           responses           response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Notify FDA of Plan Activation and Deactivation......                  2                   1                   2                  16                  32
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

                                                   Table 2--Estimated Annual Recordkeeping Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                           Number of       Number of records     Total annual     Average burden per
                Absenteeism guidance                     recordkeepers     per recordkeeper         records          recordkeeping        Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Develop Initial Plan................................                 70                   1                  70                 500              35,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Dated: March 9, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-05100 Filed 3-14-17; 8:45 am]
 BILLING CODE 4164-01-P